Author

Andreas Mahler

Observed name: A. Mahler

Observed institutions: King's College London, German Center for Neurodegenerative Diseases, Skåne University Hospital, Klinikum Bremerhaven-Reinkenheide, King's College Hospital, Parkinson-Klinik Ortenau, German Center for Neurodegenerative Diseases (DZNE) Dresden, Technische Universität Dresden

OpenAlex ID: A5042434545

Nonmotor fluctuations in Parkinson disease: Severity and correlation with motor complications

2013 · Alexander Storch, Christine B. Schneider, et al. · Neurology · 385

A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of the H3 Receptor Antagonist, GSK239512 as a Monotherapy in Subjects with Mild-to-Moderate Alzheimer’s Disease

2014 · Richard Grove, Conn Harrington, et al. · Current Alzheimer Research · 113

Comparison of IPX066 with carbidopa–levodopa plus entacapone in advanced PD patients

2014 · Fabrizio Stocchi, Ann Hsu, et al. · Parkinsonism & Related Disorders · 72

Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies

2022 · Olivier Rascol, Lars Tönges, et al. · Parkinsonism & Related Disorders · 24

Combination treatment of fingolimod with antidepressants in relapsing–remitting multiple sclerosis patients with depression: a multicentre, open-label study – REGAIN

2016 · Antonios Bayas, Katrin Schuh, et al. · Therapeutic Advances in Neurological Disorders · 22

P4‐418: A randomized, double‐blind, placebo‐controlled 16 week study of the H3 receptor antagonist GSK239512 in subjects with mild‐to‐moderate Alzheimer's disease (AD)

2011 · Richard Grove, Joseph Horrigan, et al. · Alzheimer s & Dementia

Annäherung an Wesen und Inhalte pflegerischer Handlungsprozesse in der Psychiatrie: Zur Strukturierung, Reflexion und Darstellung psychiatrischer Pflege

2004 · A. Mahler · PPH

Works count: 7

Citation count: 616

H-index: 5

I10-index: 5